A novel treatment adjunct for aspirin exacerbated respiratory disease: The low-salicylate diet: A multicenter randomized control crossover trial

International Forum of Allergy and Rhinology

Volumn 6, Issue 4, 2016, Pages 385-391

  Sommer, Doron D ^a   Rotenberg, Brian W ^b   Sowerby, Leigh J ^b   Lee, John M ^c   Janjua, Arif ^d   Witterick, Ian J ^c   Monteiro, Eric ^c   Gupta, Michael K ^a   Au, Michael ^c   Nayan, Smriti ^a,e  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e Cambridge Memorial Hospital   (Canada)

Author keywords

Aspirin exacerbated respiratory disease; Asthma; Low salicylate diet; Nasal polyps; Salicylates; Sinusitis

Indexed keywords

ADULT; AGED; ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASSESSMENT OF HUMANS; ASTHMA CONTROL QUESTIONNAIRE 7; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; FEMALE; HUMAN; LOW SALICYLATE DIET; LUND KENNEDY ENDOSCOPIC SCORE; MALE; MULTICENTER STUDY; NASAL SINUS SYMPTOM SCALE; OUTCOME ASSESSMENT; PERIOPERATIVE SINUS EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SINO NASAL OUTCOME TEST 22; CHEMICALLY INDUCED; CLINICAL TRIAL; DIET THERAPY; MIDDLE AGED; NOSE POLYP; YOUNG ADULT;

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ASTHMA, ASPIRIN-INDUCED; CROSS-OVER STUDIES; DIET THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL POLYPS; SINGLE-BLIND METHOD; YOUNG ADULT;

EID: 84954271730     PISSN: 20426976     EISSN: 20426984     Source Type: Journal    
DOI: 10.1002/alr.21678     Document Type: Article

References (59)

1. Laidlaw TM, Boyce JA Pathogenesis of aspirin-exacerbated respiratory disease and reactions. Immunol Allergy Clin North Am. 2013;33:195-210.
2. Ryan MW Diseases associated with chronic rhinosinusitis: what is the significance? Curr Opin Otolaryngol Head Neck Surg. 2008;16:231-236.
3. Steinke JW, Borish L. Factors driving the aspirin exacerbated respiratory disease phenotype. Am J Rhinol Allergy. 2015;29:35-40.
4. Widal FAP, Lermoyez J. Anaphylaxis and idiosyncraysies. Presse Med. 1922;30:189.
5. Samter M, Beers RF. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med. 1968;68:975-983.
6. Samter M, Beers RF. Concerning the nature of intolerance to aspirin. J Allergy. 1967;40:281-293.
7. Ibrahim C, Singh K, Tsai G, Huang D, et al. A retrospective study of the clinical benefit from acetylsalicyclic acid desensitization in patients with nasal polyposis and asthma. Allergy Asthma Clin Immunol. 2014;10:64.
8. Berges-Gimeno M, Simon RA, Stevenson DD. The natural history and clinical characteristics of aspirin exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2002;89:474-478.
9. Lee RU, Stevenson DD. Aspirin-exacerbated respiratory disease: evaluation and management. Allergy Asthma Immunol Res. 2011;3:3-10.
10. Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ. 2004;328:434-441
11. Sommer DD, Hoffbauer S, Au M, et al. Treatment of aspirin exacerbated respiratory disease with a low salicylate diet: a pilot crossover study. Otolaryngol Head Neck Surg. 2015;152:42-47.
12. Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J. 2000;16:432-436.
13. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol. 2003;111:913-921.
14. Rizk, H. Role of aspirin desensitization in the management of chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg. 2011;19:210-217.
15. Jenneck C, Juergens U, Buecheler M, et al. Pathogenesis, diagnosis, and treatment of aspirin intolerance. Ann Allergy Asthma Immunol. 2007;99:13.
16. Choi JH, Kim JH, Park HS, et al. Upper airways in aspirin-exacerbated respiratory disease. Curr Opin Allergy Clin Immunol. 2015;15:21-26.
17. Cook PR The role of aspirin sensitivity and nasal polyposis. Curr Opin Otolaryngol Head Neck Surg. 2002;10:213-216.
18. Klimek L, Pfaar O. Aspirin intolerance: does desensitization alter the course of the disease? Immunol Allergy Clin North Am. 2009;29:669-675.
19. Shin SW, Park BL, Chang H, et al. Exonic variants associated with development of aspirin exacerbated respiratory diseases. PLoS One. 2014;9:e111887.
20. Mitchell JE, Skypala I. Aspirin and salicylate in respiratory disease. Rhinology. 2013;51:195-205.
21. Venema DP, Hollman PCH, Janssen KP, Katan MB. Determination of acetylsalicylic acid and salicylic acid in foods, using HPLC with fluorescence detection. J Agric Food Chem. 1996;44:1762-1767.
22. Robertson GL, Kermode WJ. Salicylic acid in fresh and canned fruit and vegetables. J Sci Food Agric. 1981;32:833-836.
23. Janssen KTLPM, Hollman PCH, Venema DP, van Staveren WA, Katan MB. Salicylates in foods. Nutr Rev. 1996;54:357-359.
24. Herrman K. Occurrence and content of hydroxycinnamic and hydroxybenzoic compounds in foods. Crit Rev Food Sci Nutr. 1989;28:4315-4347.
25. Swain AR, Dutton SP, Truswell AS. Salicylates in foods. J Am Diet Assoc. 1985;85:950-960.
26. Scotter MJ, Roberts DPT, Wilson LA, et al. Free salicylic acid and acetyl salicylic acid content of foods using gas chromatography-mass spectrometry. Food Chem. 2007;105:273-279.
27. Paterson JR, Srivastava R, Baxter GJ, et al. Salicylic acid content of spices and its implications. J Agric Food Chem. 2006;54:2891-2896.
28. Wood A, Baxter G, Thies F, Kyle J, Duthie G. A systematic review of salicylates in food: estimated daily intake of a Scottish population. Mol Nutr Food Res. 2011;55(Suppl 1):S7-S14.
29. Baxter GJ, Graham AB, Lawrence JR, Wiles D, Paterson JR. Salicylic acid in soups prepared from organically and non-organically grown vegetables. Eur J Nutr. 2001;40:289-292.
30. Heiska S, Rousi M, Turtola S, Meier B, Tirkkonen V, Julkunen-Titto R. The effect of genotype and cultivation method on the total salicylate yield of dark leaved willows. Plant Medica. 2005;71:1134-1139.
31. Hare LG, Woodside JV, Young IS. Dietary salicylates. J Clin Pathol. 2003;56:649-650.
32. Umemoto J, Tsuriksawa N, Nogi S, et al. Selective cyclooxygenase-2 inhibitor cross-reactivity in aspirin exacerbated respiratory disease. Allergy Asthma Proc. 2011;32:259-261.
33. Amann R, Peskar BA. Anti-inflammatory effects of aspirin and sodium salicylate. Eur J Pharmacol. 2002;447:1-9.
34. SalicylateSensitivity.com. The Salicylate Sensitivity Cookbook. SalicylateSensitivity.com; 2009. http://www.salicylatesensitivity.com/downloads/the_salicylate_sensitivity_cookbook.pdf. Accessed November 21, 2015.
35. Rajan JP, Wineinger NE, Stevenson DD, White AA. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature. J Allergy Clin Immunol. 2015;135:676-681.
36. Cahill KN, Laidlaw TM. Aspirin exacerbated respiratory disease: the search for a biomarker. Ann Allergy Asthma Immunol. 2014;113:499-501.
37. Mascia K, Haselkorn T, Deniz YM, et al. Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma. J Allergy Clin Immunol. 2005;116:970-975.
38. Dahlén B, Boréus LO, Anderson P, Andersson R, Zetterström O. Plasma acetylsalicylic acid and salicylic acid levels during aspirin provocation in aspirin-sensitive subjects. Allergy. 1994;49:43-49.
39. Patrignani P, Dovizio M. Inside platelet-leukocyte cross-talk. Blood. 2012;119:3649-3650.
40. Xu JJ, Sowerby L, Rotenberg BW. Aspirin desensitization for aspirin-exacerbated respiratory disease (Samter's triad): a systematic review of the literature. Int Forum Allergy Rhinol. 2013;3:915-920.
41. Rotenberg BW, Zhang I, Arra I, Payton KB. Postoperative care for Samter's triad patients undergoing endoscopic sinus surgery: a double-blinded, randomized controlled trial. Laryngoscope. 2011;121:2702-2705.
42. Cho KS, Soudry E, Psaltis AJ, et al. Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease. Otolaryngol Head Neck Surg. 2014;151:575-581.
43. Kowalski ML Aspirin-sensitive rhinosinusitis and asthma. Clin Allergy Immunol. 2007;19:147-175.
44. Vento SI, Ertama LO, Hytonen ML, Wolff CH, Malmberg CH. Nasal polyposis: clinical course during 20 years. Ann Allergy Asthma Immunol. 2000;85:209-214.
45. Jantii-Alanco S, Holopainen E, Malmberg H. Recurrence of nasal polyps after surgical treatment. Rhinology. 1989;8:59-64.
46. Smith TL, Mendolia-Loffredo S, Loehrl TA, et al. Predictive factors and outcomes in endoscopic sinus surgery for chronic rhinosinusitis. Laryngoscope. 2005;115:2199-2205.
47. Robinson JL, Gries S, James KE, et al. Impact of aspirin intolerance on outcomes of sinus surgery. Laryngoscope. 2007;117:825-830.
48. Yip J, Yao CM, Lee J. State of the art: a systematic review of the surgical management of aspirin exacerbated respiratory disease. Am J Rhinol Allergy. 2014;28:493-501.
49. Kim J, Kountaki SE. The prevalence of Samter's triad patients undergoing functional endoscopic sinus surgery. Ear Nose Throat J. 2007;86:396-399.
50. Cardet JC, White AA, Barrett NA, et al. Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2014;2:208-213.
51. Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP. Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol. 2009;34:447-454.
52. Juniper EF, Svensson K, Mörk AC, Ståhl E. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med. 2005;99:553-558.
53. Morales DR, Lipworth BJ, Guthrie B, Jackson C, Donnan PT, Santiago VH. J Allergy Clin Immunol. 2014;134:40-45.
54. Moore-Robinson M, Warin RP. Effect of salicylates in urticaria. BMJ. 1967;4:262-264.
55. Doeglas HMG. Reactions to aspirin and food additives in patients with chronic urticaria including the physical urticarias. Br J of Dermatology. 1975;93:135-144.
56. Ros AM, Juhlin L, Michaelsson G. A follow-up study of patients with recurrent urticaria and hypersensitivity to aspirin, benzoates and azo dyes. Br J Dermatol. 1976;95:19-24.
57. Juhlin L. Recurrent urticaria: clinical investigation of 330 patients. Br J Dermatol. 1981;104:369-381.
58. Sweet JM, Stevenson DD, Simon RA, Mathison DA. Long-term effects of aspirin desensitization treatment for aspirin-sensitive rhinosinusitis-asthma. J Allergy Clin Immunol. 1990;85:59-65.
59. Mills EJ, Chan AW, Wu P, Vail A, Guyatt GH, Altman DG. Design, analysis and presentation of crossover trials. Trials. 2009;10:27.